Trevor Hallam

Trevor Hallam

Company: Sutro Biopharma

Job title: Chief Scientific Officer & President, Research


Providing an Overview of How Sutro Biopharma Are Targeting Folate Receptor α 4:00 pm

Discussing STRO-002 Phase 1 Clinical Study for patients with Advanced Ovarian Cancer as well as other indications Outlining how Sutro Biopharma are targeting FOLR-alphaRead more

day: day 2- pm

Industry Leaders’ Panel Discussion 8:15 am

Outlining the most exciting developments within the last 12 months Exploring what the current clinical and commercialization landscape looks like Sharing the biggest up and coming trends within the ADC field Examining the next big challenges ADC developers will faceRead more

day: day 1- am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.